Znanstveni rad - Prikaz slučaja
Autologous Platelet-Rich Plasma (PRP) for Treating Androgenetic Alopecia: A Novel Treatment Protocol Standardized on 2 Cases
Journal of Clinical Medicine, 11 (2022), 24; 7327. https://doi.org/10.3390/jcm11247327

Maletić, Ana; Dumić-Čule, Ivo; Brlek, Petar; Žic, Rado; Primorac, Dragan

Citirajte ovaj rad

Maletić, A., Dumić Čule, I., Brlek, P., Žic, R. i Primorac, D. (2022). Autologous Platelet-Rich Plasma (PRP) for Treating Androgenetic Alopecia: A Novel Treatment Protocol Standardized on 2 Cases. Journal of Clinical Medicine, 11. (24). doi: 10.3390/jcm11247327

Maletić, Ana, et al. "Autologous Platelet-Rich Plasma (PRP) for Treating Androgenetic Alopecia: A Novel Treatment Protocol Standardized on 2 Cases." Journal of Clinical Medicine, vol. 11, br. 24, 2022. https://doi.org/10.3390/jcm11247327

Maletić, Ana, Ivo Dumić Čule, Petar Brlek, Rado Žic i Dragan Primorac. "Autologous Platelet-Rich Plasma (PRP) for Treating Androgenetic Alopecia: A Novel Treatment Protocol Standardized on 2 Cases." Journal of Clinical Medicine 11, br. 24 (2022). https://doi.org/10.3390/jcm11247327

Maletić, A., et al. (2022) 'Autologous Platelet-Rich Plasma (PRP) for Treating Androgenetic Alopecia: A Novel Treatment Protocol Standardized on 2 Cases', Journal of Clinical Medicine, 11(24). doi: 10.3390/jcm11247327

Maletić A, Dumić Čule I, Brlek P, Žic R, Primorac D. Autologous Platelet-Rich Plasma (PRP) for Treating Androgenetic Alopecia: A Novel Treatment Protocol Standardized on 2 Cases. Journal of Clinical Medicine [Internet]. 09.12.2022. [pristupljeno 02.10.2024.];11(24). doi: 10.3390/jcm11247327

A. Maletić, I. Dumić Čule, P. Brlek, R. Žic i D. Primorac, "Autologous Platelet-Rich Plasma (PRP) for Treating Androgenetic Alopecia: A Novel Treatment Protocol Standardized on 2 Cases", Journal of Clinical Medicine, vol. 11, br. 24, Prosinac 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:771602. [Citirano: 02.10.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.